(Q37123817)

18 August 2017

1 reference

title

The role of PET-CT in the management of patients with advanced cancer of the head and neck (English)

1 reference

18 August 2017

Rodney J Hicks

3

0 references

Lester J. Peters

series ordinal

4

object named as

Lester J Peters

1 reference

18 August 2017

1

June Corry

1 reference

18 August 2017

2

Danny Rischin

1 reference

18 August 2017

publication date

1 March 2008

1 reference

18 August 2017

published in

Current Oncology Reports

1 reference

18 August 2017

volume

10

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

149-155

1 reference

FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11912-008-0023-X

Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-008-0023-X

Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-008-0023-X

Hybrid PET-CT simulation for radiation treatment planning in head-and-neck cancers: a brief technical report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-008-0023-X

Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-008-0023-X

Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-008-0023-X

Hypoxia in head and neck cancer: studies with hypoxic positron emission tomography imaging and hypoxic cytotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-008-0023-X

18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-008-0023-X

Whole-body PET/MRI: the future in oncological imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11912-008-0023-X

pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia

21 January 2018

1 reference

12 December 2020

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer

1 reference

12 December 2020

Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.

1 reference

12 December 2020

The occult head and neck primary: to treat or not to treat?

1 reference

12 December 2020

Whole-body imaging with PET/MRI.

1 reference

12 December 2020

Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study

1 reference

12 December 2020

Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion

1 reference

12 December 2020

Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.

1 reference

12 December 2020

PET tracer development--a tale of mice and men.

1 reference

12 December 2020

Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.

1 reference

12 December 2020

Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma

1 reference

12 December 2020

O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

1 reference

12 December 2020

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

1 reference

12 December 2020

Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer

1 reference

12 December 2020

PET/CT: a new imaging technology in nuclear medicine.

1 reference

12 December 2020

Impact of combined (18)F-FDG PET/CT in head and neck tumours

1 reference

12 December 2020

The concept of a planned neck dissection is obsolete

1 reference

12 December 2020

Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen

1 reference

12 December 2020

The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck

1 reference

12 December 2020

Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma.

1 reference

12 December 2020

2[F]-fluoro-2-deoxy-D-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation

1 reference

12 December 2020

The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma

1 reference

12 December 2020

Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study

1 reference

12 December 2020

Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation O

1 reference

12 December 2020

Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?

1 reference

12 December 2020

Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods

1 reference

12 December 2020

Detection of unknown occult primary tumors using positron emission tomography

1 reference

12 December 2020

Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer

1 reference

12 December 2020

Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas

1 reference

12 December 2020

PET with O-(2-18F-Fluoroethyl)-L-Tyrosine in peripheral tumors: first clinical results.

1 reference

12 December 2020

F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment

1 reference

12 December 2020

Cost-effectiveness of positron emission tomography for the management of potentially operable non-small cell lung cancer in Quebec

1 reference

12 December 2020

Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study.

1 reference

12 December 2020

Head and neck malignancy: is PET/CT more accurate than PET or CT alone?

1 reference

12 December 2020

Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology

1 reference

12 December 2020

Squamous carcinoma presenting as an enlarged cervical lymph node

1 reference

12 December 2020

The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor

1 reference

12 December 2020

Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers

1 reference

12 December 2020

18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer

1 reference

12 December 2020

10.1007/S11912-008-0023-X

Identifiers

DOI

1 reference

18 August 2017

1 reference